Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
ViewRay, Inc. VRAY
$0.59
-$0.17 (-28.76%)
На 18:00, 12 мая 2023
+959.32%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
108200100.00000000
-
week52high
4.96
-
week52low
0.57
-
Revenue
102206000
-
P/E TTM
-2
-
Beta
0.93529400
-
EPS
-0.58000000
-
Last Dividend
0.00000000
-
Next Earnings Date
31 июл 2023 г. в 20:00
Описание компании
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Piper Sandler | Overweight | Overweight | 03 авг 2022 г. |
| BTIG | Buy | Buy | 24 июн 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 09 мая 2022 г. |
| Piper Sandler | Overweight | Overweight | 06 мая 2022 г. |
| Stifel | Buy | 25 янв 2022 г. | |
| Morgan Stanley | Equal-Weight | Equal-Weight | 11 окт 2022 г. |
| Piper Sandler | Overweight | Overweight | 02 ноя 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 02 ноя 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 18 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Burke William P. Mr. | A | 252632 | 252632 | 16 янв 2023 г. |
| Moore Daniel Jeffrey | A | 353872 | 26363 | 03 янв 2023 г. |
| WILENSKY GAIL R | A | 210393 | 12727 | 03 янв 2023 г. |
| Drake Scott William | D | 3824764 | 96546 | 03 янв 2023 г. |
| Castelein Caley | A | 898477 | 16590 | 03 янв 2023 г. |
| SCHNABEL SUSAN C | A | 203699 | 10909 | 03 янв 2023 г. |
| Spencer Phillip M | A | 155029 | 12727 | 03 янв 2023 г. |
| SCHNABEL SUSAN C | A | 192790 | 200 | 28 ноя 2022 г. |
| SCHNABEL SUSAN C | A | 192590 | 100 | 28 ноя 2022 г. |
| SCHNABEL SUSAN C | A | 192490 | 8638 | 28 ноя 2022 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | 1939329 | 15546 | 30 сент 2022 г. |
| Vanguard Total Stock Market Index Fund | 2552310 | 0 | 31 авг 2020 г. |
| iShares Russell 2000 ETF | 2433880 | 69768 | 31 авг 2020 г. |
| Fidelity Select Medical Technology and Devices Portfolio | 8000000 | 0 | 31 июл 2020 г. |
| Baron Discovery Fund | 1985000 | 0 | 31 июл 2020 г. |
| Vanguard Extended Market Index Fund | 1549450 | -4150 | 31 июл 2020 г. |
| Swedbank Robur Medica | 1350000 | 0 | 31 июл 2020 г. |
| Artisan International Small-Mid Fund | 4614490 | 1646920 | 30 июн 2020 г. |
| Fidelity Small Cap Growth Fund | 2881880 | 407400 | 30 апр 2020 г. |
| Needham Small Cap Growth Fund | 1100000 | 885000 | 31 мар 2020 г. |
Новостная лента
ViewRay (VRAY) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
10 мая 2023 г. в 18:59
ViewRay (VRAY) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.14 per share a year ago.
ViewRay: Shares Crater As Company Warns Of Slower Growth, Higher Cash Burn
Seeking Alpha
13 апр 2023 г. в 19:28
Magnetic resonance imaging-guided radiation therapy system provider ViewRay, Inc. has shocked investors with a severe revenue and cash flow warning. Expected 2023 revenue growth range slashed from a range of 25% to 40% to a new range of 0% to 15%.
ViewRay Announces Conference Call for Preliminary First Quarter 2023 Financial Results to be held Pre-Market opening on April 13, 2023
PRNewsWire
12 апр 2023 г. в 17:25
DENVER , April 12, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) will hold a conference call to discuss results on Thursday, April 13, 2023, at 8:00 AM ET. The dial-in number for domestic callers is (888) 886-7786.
Penny Stocks To Buy Now? 7 With Unusual Options Volume This Week
PennyStocks
31 мар 2023 г. в 11:16
Penny stocks with unusual options activity. The post Penny Stocks To Buy Now?
ViewRay, Inc. (VRAY) Q4 2022 Earnings Call Transcript
Seeking Alpha
27 февр 2023 г. в 20:42
ViewRay, Inc. (NASDAQ:VRAY ) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ET Company Participants Matt Harrison - Director of IR Scott Drake - President and CEO Bill Burke - CFO Conference Call Participants Rick Wise - Stifel Jason Bednar - Piper Sandler Chris Pasquale - Nephron Research Suraj Kalia - Oppenheimer Operator Good afternoon, ladies and gentlemen. And welcome to the ViewRay Q4 2022 Earnings Call.